Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Physiology. Endocrinology and Metabolism

• Publication date

  2007-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1152/AJPENDO.00003.2007PMID 17652154
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A1 adenosine receptor partial agonist lowers plasma FFA and improves insulin resistance induced by high-fat diet in rodents.

  2007cited by this paper
• A FlAsH-based FRET approach to determine G protein–coupled receptor activation in living cells

  2005cited by this paper
• Functional Selectivity of G Protein Signaling by Agonist Peptides and Thrombin for the Protease-activated Receptor-1*[boxs]

  2005cited by this paper
• Identification of neuromedin S and its possible role in the mammalian circadian oscillator system

  2005cited by this paper
• Obestatin, a Peptide Encoded by the Ghrelin Gene, Opposes Ghrelin's Effects on Food Intake

  2005cited by this paper
• Real-time monitoring of receptor and G-protein interactions in living cells

  2005cited by this paper
• Techniques: promiscuous Galpha proteins in basic research and drug discovery.

  2005cited by this paper
• Paracrine regulation of ovarian granulosa cell differentiation by stanniocalcin (STC) 1: mediation through specific STC1 receptors.

  2004cited by this paper
• G16-mediated Activation of Nuclear Factor κB by the Adenosine A1 Receptor Involves c-Src, Protein Kinase C, and ERK Signaling*

  2004cited by this paper
• A1 Adenosine Receptor Agonists: Medicinal Chemistry and Therapeutic Potential

  2004cited by this paper
• Neuromedin U and Its Receptors: Structure, Function, and Physiological Roles

  2004cited by this paper
• G Protein Signaling: Insights from New Structures

  2004cited by this paper
• A(1) adenosine receptor agonists: medicinal chemistry and therapeutic potential.

  2004cited by this paper
• The G protein-coupled receptor repertoires of human and mouse

  2003cited by this paper
• Insights into G protein structure, function, and regulation.

  2003cited by this paper
• Development of a high-throughput bioassay to screen melatonin receptor agonists using human melatonin receptor expressing CHO cells.

  2003cited by this paper
• Signalling: Seven-transmembrane receptors

  2002cited by this paper
• G Protein Pathways

  2002cited by this paper
• Regulation of glycogen metabolism in hepatocytes through adenosine receptors. Role of Ca2+ and cAMP.

  2002cited by this paper
• A1 adenosine receptor activation inhibits neurite process formation by rho kinase-mediated pathways

  2001cited by this paper
• Identification and Characterization of Two Neuromedin U Receptors Differentially Expressed in Peripheral Tissues and the Central Nervous System*

  2000cited by this paper
• Identification of receptors for neuromedin U and its role in feeding

  2000influential reference
• The role of Rho in G protein-coupled receptor signal transduction.

  2000cited by this paper
• Incorporation of Galpha(z)-specific sequence at the carboxyl terminus increases the promiscuity of galpha(16) toward G(i)-coupled receptors.

  2000influential reference
• Molecular tinkering of G protein‐coupled receptors: an evolutionary success

  1999cited by this paper
• Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.

  1998cited by this paper
• Activation of various subtypes of G-protein alpha subunits by partial agonists of the adenosine A1 receptor.

  1998cited by this paper
• Direct stimulation of Bruton's tyrosine kinase by G(q)-protein alpha-subunit.

  1997cited by this paper
• Direct stimulation of Bruton's tyrosine kinase by Gq-protein α-subunit

  1997cited by this paper
• Heterotrimeric G proteins.

  1996cited by this paper
• Carboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation.

  1996cited by this paper
• GTPase mechanism of Gproteins from the 1.7-A crystal structure of transducin alpha-GDP-AIF-4.

  1995cited by this paper
• Purinergic inhibition of neurotransmitter release in the central nervous system.

  1995cited by this paper
• Adenosine A1 receptor-mediated activation of phospholipase C-beta 3 in intestinal muscle: dual requirement for alpha and beta gamma subunits of Gi3.

  1995cited by this paper
• Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

  1995cited by this paper
• GTPase mechanism of Gproteins from the 1.7-Å crystal structure of transducin α - GDP AIF−4

  1994cited by this paper
• G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets.

  1994influential reference
• A single species of A1 adenosine receptor expressed in Chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release.

  1994cited by this paper
• Agonist‐specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems.

  1994cited by this paper
• Substitution of three amino acids switches receptor specificity of Gqα to that of Giα

  1993cited by this paper
• Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha.

  1993influential reference
• The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor.

  1991cited by this paper
• Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal tract and brain of the rat.

  1988cited by this paper
• Topographic localization of neuromedin U-like structures in the rat brain: an immunohistochemical study.

  1987cited by this paper
• Neuromedins: novel smooth-muscle stimulating peptides identified in porcine spinal cord.

  1985cited by this paper
• Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site.

  1985cited by this paper

• Neuromedin U Signaling Map: Toward Neuropeptide Focused Therapeutic Targets in Cancer and Human Diseases.

  2026cites this paper
• The Neuromedin U system: pharmacological implications for the treatment of obesity and binge eating behavior.

  2023cites this paper
• Pharmacomodulation of brain neuromedin U signaling as a potential therapeutic strategy

  2023cites this paper
• Neuromedin U receptors in GtoPdb v.2023.1

  2023cites this paper
• Neuromedin S Regulates Steroidogenesis through Maintaining Mitochondrial Morphology and Function via NMUR2 in Goat Ovarian Granulosa Cells

  2022cites this paper
• Escitalopram alters local expression of noncanonical stress-related neuropeptides in the rat brain via NPS receptor signaling

  2022cites this paper
• Increased NMUR1 Expression in Mast Cells in the Synovial Membrane of Obese Osteoarthritis Patients

  2022cites this paper
• Modulatory effect of long-term treatment with escitalopram and clonazepam on the expression of anxiety-related neuropeptides: neuromedin U, neuropeptide S and their receptors in the rat brain

  2022cites this paper
• Neuromedin U uses Gαi2 and Gαo to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic β cells

  2021cites this paper
• Neuromedin U, a Key Molecule in Metabolic Disorders

  2021cites this paper
• Neuromedins NMU and NMS: An Updated Overview of Their Functions

  2021influential citation
• Neuromedin U modulates neuronal excitability in rat hippocampal slices.

  2021cites this paper
• Identification of vascular dementia and Alzheimer's disease hub genes expressed in the frontal lobe and temporal cortex by weighted co-expression network analysis and construction of a protein–protein interaction

  2021cites this paper
• The Specificity of Downstream Signaling for A1 and A2AR Does Not Depend on the C-Terminus, Despite the Importance of This Domain in Downstream Signaling Strength

  2020influential citation
• Neuromedin U: potential roles in immunity and inflammation

  2020cites this paper
• Effect of neuromedin U on allergic airway inflammation in an asthma model

  2019cites this paper
• Neuromedin U receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Light control of G protein signaling pathways by a novel photopigment

  2018cites this paper
• Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor

  2018cites this paper
• Neuromedin U suppresses glucose-stimulated insulin secretion in pancreatic β cells.

  2017cites this paper
• The role of ligand processing in neuromedin U receptor signalling and regulation

  2016cites this paper
• Neuromedin U: a multifunctional neuropeptide with pleiotropic roles.

  2015cites this paper
• Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro

  2015cites this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cites this paper
• Novel Screening Assay for the Selective Detection of G-Protein-Coupled Receptor Heteromer Signaling

  2013cites this paper
• The role of hydrophobic amino acids in the structure and function of the rhodopsin family of G protein-coupled receptors.

  2013cites this paper
• Chimeric Yeast G-Protein α Subunit Harboring a 37-Residue C-Terminal Gustducin-Specific Sequence Is Functional in Saccharomyces cerevisiae

  2012cites this paper
• Signalling, Desensitization and Resensitization of Neuromedin U Receptors

  2011cites this paper
• Non-Edg family LPA receptors: the cutting edge of LPA research.

  2011cites this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cites this paper
• Orthologue selectivity and ligand bias: translating the pharmacology of GPR35.

  2011cites this paper
• Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons.

  2010cites this paper
• Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S

  2009cites this paper
• Guide to Receptors and Channels (GRAC), 4th edition

  2009cites this paper
• Characterizing Cannabinoid CB 2 Receptor Ligands Using DiscoveRx PathHunter™ β-Arrestin Assay

  2009cites this paper
• Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA6*

  2009cites this paper
• Establishment of a chimeric reporting system for the universal detection and high-throughput screening of G protein-coupled receptors.

  2009cites this paper
• THEMED ISSUE: GPCR REVIEW Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S

  2009cites this paper
• Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system.

  2008cites this paper
• Distribution of neuromedin U binding sites in the rat CNS revealed by in vitro receptor autoradiography.

  2008cites this paper